Table 6. – The correlation between osteoprotegerin and other variables.
| No renal dysfunction | With renal dysfunction | |||
|---|---|---|---|---|
| r | p | r | p | |
| GFR (CKD-EPI) (ml/min/1.73 m2) | 0.248 | 0.086 | -0.135 | 0.478 |
| Blood pressure | ||||
| Peripheral SBP (mmHg) | -0.001 | 0.995 | 0.426 | 0.019 |
| Peripheral DBP (mmHg) | -0.101 | 0.492 | 0.286 | 0.126 |
| Central blood pressure measurement | ||||
| Central SBP (mmHg) | 0.005 | 0.972 | 0.409 | 0.025 |
| Central DBP (mmHg) | -0.053 | 0.719 | 0.080 | 0.675 |
| cPP (mmHg) | 0.159 | 0.275 | 0.496 | 0.005 |
| PWV (m/sec) | -0.205 | 0.158 | 0.483 | 0.007 |
| Aix (%) | 0.094 | 0.518 | 0.369 | 0.045 |
| FMD (%) | -0.002 | 0.164 | -0.010 | 0.959 |
Pearson’s or Spearman’s correlation test. Aix: index augmentation. CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; FMD: flow-mediated dilation; PWV: pulse wave velocity; DBP: diastolic blood pressure; SBP: systolic blood pressure; GFR: glomerular filtration rate; cPP: central pulse pressure.